Hellman Jordan Management Company Has Increased Intercontinental Exchange (ICE) Stake; Sangamo Therapeutics (SGMO) Covered By 4 Bulls

May 23, 2017 - By wolcottdaily

Hellman Jordan Management Company Inc increased Intercontinental Exchange (ICE) stake by 400% reported in 2016Q4 SEC filing. Hellman Jordan Management Company Inc acquired 18,528 shares as Intercontinental Exchange (ICE)’s stock rose 1.58%. The Hellman Jordan Management Company Inc holds 23,160 shares with $1.31M value, up from 4,632 last quarter. Intercontinental Exchange now has $35.58B valuation. The stock rose 0.82% or $0.49 reaching $59.95 per share. About 1.05M shares traded. Intercontinental Exchange Inc (NYSE:ICE) has risen 13.80% since May 23, 2016 and is uptrending. It has underperformed by 2.90% the S&P500.

Among 9 analysts covering Sangamo Biosciences (NASDAQ:SGMO), 4 have Buy rating, 1 Sell and 4 Hold. Therefore 44% are positive. Sangamo Biosciences had 12 analyst reports since August 8, 2015 according to SRatingsIntel. The company was maintained on Friday, September 4 by Cowen & Co. The firm has “Outperform” rating given on Friday, December 4 by Wells Fargo. Piper Jaffray downgraded Sangamo Therapeutics Inc (NASDAQ:SGMO) on Wednesday, October 19 to “Neutral” rating. As per Tuesday, September 8, the company rating was downgraded by Zacks. The stock of Sangamo Therapeutics Inc (NASDAQ:SGMO) earned “Neutral” rating by Janney Capital on Thursday, August 4. The stock has “Overweight” rating by JP Morgan on Saturday, August 8. Wedbush downgraded it to “Neutral” rating and $4 target in Tuesday, November 1 report. JP Morgan maintained the stock with “Buy” rating in Thursday, September 3 report. PiperJaffray downgraded the stock to “Neutral” rating in Wednesday, October 19 report. Jefferies maintained Sangamo Therapeutics Inc (NASDAQ:SGMO) rating on Wednesday, September 2. Jefferies has “Buy” rating and $12 target. See Sangamo Therapeutics Inc (NASDAQ:SGMO) latest ratings:

Hellman Jordan Management Company Inc decreased Borg Warner (NYSE:BWA) stake by 14,400 shares to 14,052 valued at $554,000 in 2016Q4. It also reduced United Continental Holdings (NYSE:UAL) stake by 6,000 shares and now owns 19,350 shares. Gilead Sciences (NASDAQ:GILD) was reduced too.

Investors sentiment increased to 11.77 in Q4 2016. Its up 10.76, from 1.01 in 2016Q3. It is positive, as 32 investors sold ICE shares while 16 reduced holdings. 77 funds opened positions while 488 raised stakes. 1.03 billion shares or 903.33% more from 102.32 million shares in 2016Q3 were reported. Sprott Incorporated reported 295,375 shares or 1.43% of all its holdings. Thomas White Interest Ltd has 0.13% invested in Intercontinental Exchange Inc (NYSE:ICE). Howe & Rusling Incorporated owns 86,716 shares for 1.07% of their portfolio. Winslow Cap Limited Liability holds 1.19% or 4.60M shares. Massmutual Fsb Adv holds 0% or 295 shares in its portfolio. Associated Banc invested in 0.02% or 4,435 shares. First Allied Advisory Ser, a Missouri-based fund reported 8,831 shares. 7,330 are owned by Tctc Ltd Liability Co. Invesco Limited owns 0.03% invested in Intercontinental Exchange Inc (NYSE:ICE) for 1.45M shares. Quantum Capital holds 0.1% or 6,725 shares. X Mngmt Commerce Lc reported 0.02% of its portfolio in Intercontinental Exchange Inc (NYSE:ICE). Stifel Fin stated it has 147,487 shares. Moreover, Gulf Interest Bank & Trust (Uk) has 0.15% invested in Intercontinental Exchange Inc (NYSE:ICE). Stephens Ar holds 10,262 shares. Comerica State Bank holds 0.11% in Intercontinental Exchange Inc (NYSE:ICE) or 240,959 shares.

Among 12 analysts covering Intercontinental Exchange (NYSE:ICE), 9 have Buy rating, 0 Sell and 3 Hold. Therefore 75% are positive. Intercontinental Exchange had 37 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of Intercontinental Exchange Inc (NYSE:ICE) earned “Overweight” rating by Barclays Capital on Friday, September 4. The firm has “Overweight” rating by Barclays Capital given on Tuesday, December 15. As per Friday, January 8, the company rating was maintained by Deutsche Bank. Standpoint Research maintained Intercontinental Exchange Inc (NYSE:ICE) on Sunday, August 9 with “Hold” rating. The firm earned “Buy” rating on Thursday, May 19 by Buckingham Research. On Friday, March 31 the stock rating was reinitiated by RBC Capital Markets with “Sector Perform”. The rating was maintained by Deutsche Bank on Thursday, August 4 with “Buy”. The firm has “Buy” rating by Goldman Sachs given on Friday, May 6. The firm has “Sector Perform” rating by RBC Capital Markets given on Tuesday, May 10. The rating was maintained by Wood with “Buy” on Thursday, April 13.

About 1.02 million shares traded. Sangamo Therapeutics Inc (NASDAQ:SGMO) has risen 29.78% since May 23, 2016 and is uptrending. It has outperformed by 13.08% the S&P500.

Sangamo Therapeutics, Inc., formerly Sangamo BioSciences, Inc., is a clinical-stage biotechnology company. The company has market cap of $544.54 million. The Firm is focused on translating science into genomic therapies that transform patients’ lives using the Company’s platform technologies in genome editing, gene therapy, gene regulation and cell therapy. It currently has negative earnings. The Firm has clinical and preclinical programs in development and partnered certain programs with biopharmaceutical companies to expedite clinical and commercial development.

Investors sentiment decreased to 1.15 in Q4 2016. Its down 0.06, from 1.21 in 2016Q3. It fall, as 17 investors sold Sangamo Therapeutics Inc shares while 31 reduced holdings. 18 funds opened positions while 37 raised stakes. 39.96 million shares or 8.31% less from 43.58 million shares in 2016Q3 were reported. 372,768 were reported by Credit Suisse Ag. 213,766 were reported by Blackrock Advisors. Swiss Retail Bank accumulated 113,560 shares or 0% of the stock. Bank Of Mellon stated it has 314,163 shares or 0% of all its holdings. Ubs Asset Mgmt Americas holds 10,298 shares. Dimensional Fund Advsrs Ltd Partnership invested in 0% or 128,251 shares. Goldman Sachs Grp Inc Inc holds 0% or 174,455 shares in its portfolio. Royal Financial Bank Of Canada invested in 8,111 shares or 0% of the stock. Alliancebernstein L P accumulated 100,441 shares. Qs Investors Llc reported 0% stake. Price T Rowe Associates Inc Md reported 0% of its portfolio in Sangamo Therapeutics Inc (NASDAQ:SGMO). Nationwide Fund Advsrs invested in 0% or 44,389 shares. Citadel Limited owns 119,700 shares for 0% of their portfolio. Zurcher Kantonalbank (Zurich Cantonalbank) invested in 2,347 shares or 0% of the stock. Moreover, Davenport Lc has 0% invested in Sangamo Therapeutics Inc (NASDAQ:SGMO).